A letter from HHS Secretary Robert F Kennedy Jr. and FDA Commissioner Martin Makary, in which they confirmed that the FDA is ...

The drug – which will be sold in the US under the Inluriyo trade name – is only the second drug in the oral SERD category to ...

While patients themselves may not know the source of their compounded drug, 503A vs 503B pharmacies have a direct effect on ...

All of the DTC channels offer discounts for people willing and able to pay for medicines with cash, and that also applies to ...

The Houston facility has been selected as one that will make orforglipron, Lilly's new oral GLP-1 agonist for weight-loss, ...

In this episode of our Frontiers Health limited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks ...

For more information about Axtria, please visit: www.axtria.com ...

The Moderna Innovation and Technology Centre (MITC) in Harwell is the flagship part of a 10-year, £1 billion investment in ...

The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it ...

Investors in Verona – a specialist in respiratory medicines – overwhelmingly gave their blessing to MSD's $107-per-share ...

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy ...

The San Diego-based company claims a number of firsts for its coin-sized Biolinq Shine device, including that it is so far ...